<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04169035</url>
  </required_header>
  <id_info>
    <org_study_id>P/2019/435</org_study_id>
    <nct_id>NCT04169035</nct_id>
  </id_info>
  <brief_title>The BD Odon DeviceTM for Assisted Vaginal Birth: a Feasibility Study to Investigate Safety and Efficacy</brief_title>
  <acronym>ASSIST</acronym>
  <official_title>The BD Odon DeviceTM for Assisted Vaginal Birth: a Feasibility Study to Investigate Safety and Efficacy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Besancon ASSIST study will investigate if the BD Odon DeviceTM is safe, effective and&#xD;
      acceptable to women and maternity staff for assisted vaginal birth.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 4, 2019</start_date>
  <completion_date type="Anticipated">June 15, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of births successfully assisted with the BD Odon Device</measure>
    <time_frame>3 months after delivery</time_frame>
    <description>Successful vaginal birth with the BD ODON DeviceTM: successful BD Odon assisted birth in the absence of maternal and neonatal serious adverse reactions</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">104</enrollment>
  <condition>Pregnant Woman</condition>
  <arm_group>
    <arm_group_label>Odon device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The practitioner providing the woman's care in labour determines that she requires an assisted vaginal birth, and there is no obstetric indication for an alternative method of assiste vaginal birth. Odon trained practitioner available to assist the birth.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Forceps or ventouse</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The practitioner providing the woman's care in labour determines that she requires an assisted vaginal birth, and there is no obstetric indication for an alternative method of assisted vaginal birth.&#xD;
The woman is unable to have an Odon assisted birth as no Odon trained practitioner is available to assist the birth.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>The BD Odon DeviceTM is a new device for AVB that has been designed by a team of midwives, doctors and engineers.</intervention_name>
    <description>The BD Odon DeviceTM works by placing a cuff of air attached to a plastic sleeve, around the baby's head. The doctor then gently pulls on this sleeve and air cuff to assist the birth of the baby.</description>
    <arm_group_label>Odon device</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>forceps or ventouse</intervention_name>
    <description>The woman is unable to have an Odon assisted birth as no Odon trained practitioner is available to assist the birth.&#xD;
Forceps is a metal instrument with two handles used to encircle a baby's head and assist in birth.&#xD;
Ventouse is a device used to help a baby be born by putting it over the baby's head and using suction (= removing air) to pull the baby out of the mother's body.</description>
    <arm_group_label>Forceps or ventouse</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The woman is ≥18 years of age&#xD;
&#xD;
          -  The woman has a singleton pregnancy&#xD;
&#xD;
          -  The pregnancy is ≥28+0 weeks' gestation&#xD;
&#xD;
          -  There is a negative antenatal screen for HIV and Hepatitis B&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The woman does not fulfil all of the inclusion criteria listed&#xD;
&#xD;
          -  There is a diagnosis of a fetal skull abnormality precluding AVB (i.e. macrocephaly)&#xD;
&#xD;
          -  There is a known osteogenesis imperfecta affected pregnancy&#xD;
&#xD;
          -  There is suspicion of a fetal bleeding disorder (von Willebrand's disease, AITP,&#xD;
             haemophilia)&#xD;
&#xD;
          -  There is an intrauterine fetal death in the current pregnancy&#xD;
&#xD;
          -  The woman is sensitive to latex&#xD;
&#xD;
          -  The woman is currently serving a prison sentence&#xD;
&#xD;
          -  The woman lacks capacity to consent&#xD;
&#xD;
          -  The woman has a lack of ability to read or understand French as this would preclude&#xD;
             successful completion of questionnaires&#xD;
&#xD;
          -  The woman has received intramuscular or intravenous opiates (i.e. pethidine or&#xD;
             morphine) within the past 6 hours&#xD;
&#xD;
          -  The woman is in established labour (≥ 4cm cervical dilatation) without regional&#xD;
             analgesia in place&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>pregnant women</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Louis BENAZET</last_name>
    <phone>+33 381 219 147</phone>
    <email>lbenazet@chu-besancon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chu Besancon</name>
      <address>
        <city>Besançon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Louis BENAZET</last_name>
    </contact>
    <investigator>
      <last_name>Nicolas Mottet</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>November 14, 2019</study_first_submitted>
  <study_first_submitted_qc>November 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 19, 2019</study_first_posted>
  <last_update_submitted>March 4, 2021</last_update_submitted>
  <last_update_submitted_qc>March 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

